Clinical trial NCT05469828 - References

Sickle Cell Disease — Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia

Citation(s)

•   Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA, et al
  Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb;19(1):110-29. doi: 10.1016/s0197-2456(97)00099-8.
•   Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D
  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 2;339(1):5-11. doi: 10.1056/NEJM199807023390102.
•   Chien S, Usami S, Bertles JF
  Abnormal rheology of oxygenated blood in sickle cell anemia. J Clin Invest. 1970 Apr;49(4):623-34. doi: 10.1172/JCI106273.
•   De Blasi RA, Cope M, Ferrari M
  Oxygen consumption of human skeletal muscle by near infrared spectroscopy during tourniquet-induced ischemia in maximal voluntary contraction. Adv Exp Med Biol. 1992;317:771-7. doi: 10.1007/978-1-4615-3428-0_94. No abstract available.
•   Delpy DT, Cope MC, Cady EB, Wyatt JS, Hamilton PA, Hope PL, Wray S, Reynolds EO
  Cerebral monitoring in newborn infants by magnetic resonance and near infrared spectroscopy. Scand J Clin Lab Invest Suppl. 1987;188:9-17.
•   Detterich JA, Kato RM, Rabai M, Meiselman HJ, Coates TD, Wood JC
  Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood. 2015 Aug 6;126(6):703-10. doi: 10.1182/blood-2014-12-614370. Epub 2015 Jun 2.
•   Friedman D, Szmuszkovicz J, Rabai M, Detterich JA, Menteer J, Wood JC
  Systemic endothelial dysfunction in children with idiopathic pulmonary arterial hypertension correlates with disease severity. J Heart Lung Transplant. 2012 Jun;31(6):642-7. doi: 10.1016/j.healun.2012.02.020. Epub 2012 Mar 21.
•   Gordeuk VR, Castro OL, Machado RF
  Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood. 2016 Feb 18;127(7):820-8. doi: 10.1182/blood-2015-08-618561. Epub 2016 Jan 12.
•   ITANO HA, PAULING L
  A rapid diagnostic test for sickle cell anemia. Blood. 1949 Jan;4(1):66-8. No abstract available.
•   Kato GJ, Gladwin MT, Steinberg MH
  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007 Jan;21(1):37-47. doi: 10.1016/j.blre.2006.07.001. Epub 2006 Nov 7.
•   Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT
  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009 Sep;84(9):618-25. doi: 10.1002/ajh.21475.
•   Lee JH, Jang YE, Song IK, Kim EH, Kim HS, Kim JT
  Near-Infrared Spectroscopy and Vascular Occlusion Test for Predicting Clinical Outcome in Pediatric Cardiac Patients: A Prospective Observational Study. Pediatr Crit Care Med. 2018 Jan;19(1):32-39. doi: 10.1097/PCC.0000000000001386.
•   Nathan DG
  Regulation of fetal hemoglobin synthesis by cell cycle specific drugs. Prog Clin Biol Res. 1985;191:475-500. No abstract available.
•   Nilsson GE, Tenland T, Oberg PA
  Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng. 1980 Oct;27(10):597-604. doi: 10.1109/TBME.1980.326582. No abstract available.
•   Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, Malik P, Taylor MD, Quinn CT
  Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood. 2017 Jul 13;130(2):205-213. doi: 10.1182/blood-2017-02-767624. Epub 2017 May 15.
•   PAULING L, ITANO HA, et al
  Sickle cell anemia a molecular disease. Science. 1949 Nov 25;110(2865):543-8. doi: 10.1126/science.110.2865.543. No abstract available.
•   Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP
  Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994 Jun 9;330(23):1639-44. doi: 10.1056/NEJM199406093302303.
•   Presley TD, Perlegas AS, Bain LE, Ballas SK, Nichols JS, Sabio H, Gladwin MT, Kato GJ, Kim-Shapiro DB
  Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes. Hemoglobin. 2010;34(1):24-36. doi: 10.3109/03630260903546999.
•   Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT
  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002 Dec;8(12):1383-9. doi: 10.1038/nm1202-799. Epub 2002 Nov 11.
•   Steiner CA, Miller JL
  Sickle Cell Disease Patients in U.S. Hospitals, 2004. 2006 Dec. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Statistical Brief #21. Available from http://www.ncbi.nlm.nih.gov/books/NBK63489/
•   Tenland T, Salerud EG, Nilsson GE, Oberg PA
  Spatial and temporal variations in human skin blood flow. Int J Microcirc Clin Exp. 1983;2(2):81-90.
•   Thorniley MS, Houston R, Wickramasinghe YA, Rolfe P
  Application of near-infrared spectroscopy for the assessment of the oxygenation level of myoglobin and haemoglobin in cardiac muscle in vivo. Biochem Soc Trans. 1990 Dec;18(6):1195-6. doi: 10.1042/bst0181195. No abstract available.

Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia

Details for clinical trial NCT05469828